New Delhi, Jan 29 (PTI) The preliminary public provide of Temasek Holdings and TPG-backed Dr Agarwal’s Well being Care Ltd, an eye fixed care providers supplier, acquired 7 per cent subscription on the primary day of bidding on Wednesday.
The general public problem received bids for 38,08,980 shares in opposition to 5,35,26,172 shares on provide, as per NSE knowledge.
The portion for Retail Particular person Traders (RIIs) fetched 11 per cent subscription whereas the class for non-institutional buyers acquired 6 per cent subscription.
Dr Agarwal’s Well being Care on Tuesday stated it has raised over ₹875.5 crore from anchor buyers.
The ₹3,027.26-crore public problem, with a worth band of ₹382 to ₹402 per share, will conclude on January 31.
The IPO is a mixture of a contemporary problem of as much as ₹300 crore and an Provide For Sale (OFS) of as much as 6.78 crore fairness shares price ₹2,727.26 crore by promoters and different promoting shareholders on the higher finish of the worth band.
These promoting shares within the OFS embody Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.
Proceeds from the contemporary problem to the tune of ₹195 crore shall be used for cost of debt. In addition to, a portion shall be used for basic company functions and unidentified inorganic acquisitions.
Dr Agarwal’s Well being Care provides a wide selection of providers, together with cataract, refractive, and different surgical procedures, consultations, prognosis, non-surgical remedies, and the sale of optical merchandise, contact lenses, equipment, and eye care-related pharmaceutical gadgets.
As of September 2024, its community consisted of 193 services with a majority focus in South India, notably Chennai, Hyderabad and Bengaluru, adopted by Western India.
Kotak Mahindra Capital Firm, Morgan Stanley India Firm, Jefferies India and Motilal Oswal Funding Advisors are the book-running lead managers to the difficulty.
